Physician profile
Leah D Lowman
NPI 1831198282
$3,597.12
in general payments reported to CMS, 2019-2025
34 companies · $515 in 2025
The $515 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $605 · 2021: $720 · 2022: $651 · 2023: $365 · 2024: $349 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.18 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $779.30 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $422.50 | 2019-2025 | |
| Astellas Pharma US INC | $345.27 | 2021-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $284.76 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $168.30 | 2019-2023 | Injectafer |
| Therapeuticsmd, INC. | $157.18 | 2019-2022 | |
| Organon LLC | $140.80 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $112.89 | 2019-2025 | Paragard T 380a, Summit Doppler |
| Myovant Sciences INC. | $111.86 | 2021-2022 | |
| Lupin INC. | $83.19 | 2020-2021 | |
| Biogen, INC. | $81.04 | 2025 | Zurzuvae |
| Millicent US INC | $78.11 | 2020-2024 | Intrarosa, Femring |
| Mayne Pharma Commercial LLC | $72.40 | 2021-2025 | |
| Amag Pharmaceuticals, INC. | $60.69 | 2019-2020 | |
| Evofem Biosciences, INC. | $60.03 | 2021-2023 | Phexxi |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $59.40 | 2021-2022 | |
| Hologic Sales and Service, LLC | $58.85 | 2020-2025 | Aptima |
| Sumitomo Pharma America, INC. | $54.06 | 2024-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $53.41 | 2019-2024 | Gardasil, Gardasil 9 |
| Mylan Pharmaceuticals INC. | $52.93 | 2020-2021 | |
| Avion Pharmaceuticals | $49.20 | 2021-2022 | |
| Exact Sciences Corporation | $47.68 | 2023-2024 | Cologuard Collection Kit |
| Allergan, INC. | $43.47 | 2019-2020 | |
| Amgen INC. | $32.20 | 2024-2025 | Evenity, Prolia, Prolia |
| Optumhealth Care Solutions, LLC | $28.84 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $20.40 | 2020 | |
| Ethicon US, LLC | $20.29 | 2019 | |
| Pfizer INC. | $20.02 | 2025 | |
| Stryker Corporation | $19.69 | 2022 | |
| Dexcom, INC. | $18.04 | 2023 | Dexcom G6 Transmitter |
| Davol INC. | $16.43 | 2020 | |
| Scynexis, INC. | $15.69 | 2022 | |
| Roche Diagnostics Corporation | $14.76 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Lowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.